Singapore – Omnicom Media Group agency Hearts & Science has secured two new pharmaceutical clients in Asia, further expanding its presence in the region’s healthcare marketing sector.
The agency has been appointed to handle media duties for Hyphens Pharma in Singapore and Allergan in Taiwan, following competitive pitches in both markets. These wins add to Hearts & Science’s growing momentum in Asia Pacific, where it recently picked up accounts including Warner Bros. Discovery and AS Watson.
In Singapore, Hearts & Science will oversee integrated media planning for Hyphens Pharma, whose consumer healthcare portfolio includes brands such as Ceradan, D-Vita, Fluanxol, and Rupafin. The agency was selected for its ability to align media strategies with brand goals, analyse audience behaviours, and provide data-driven insights that support omnichannel planning.
Meanwhile, in Taiwan, the agency secured the Allergan business by developing a media strategy that reinforced the company’s leadership in aesthetic medicine.
Rochelle Chhaya, CEO of Hearts & Science APAC, said the latest client additions are a testament to the agency’s growing pharmaceutical capabilities.
“These new business wins deepen our pharmaceutical expertise and reflect the innovative talent that forms a crucial foundation for Hearts & Science,” Chhaya said. “We are constantly seeking new ways to help brands build connections that matter and be where their consumers are,” she said.
She added that the partnerships signal growing trust in the agency’s regional capabilities and position it for continued expansion in the healthcare sector.
